Displaying 37 - 54 of 124
Tests Identify When Advanced Prostate Cancer Therapies Would Benefit
Two blood tests can predict which subset of men with advanced prostate cancer will likely not benefit from anti-androgen therapies, providing doctors and patient added clarity on treatment options, according to a study led by Duke Cancer Institute . The blood tests, dubbed “liquid biopsies”, detect...
Black Patients Show Stronger Response to Hormone Therapy for Prostate Cancer
African-American men with advanced prostate cancer might be more responsive than white men to an anti-androgen drug and steroids, according to a study led by Duke Cancer Institute researchers. While median survival was similar for both black and white participants in the study, the findings...
Analysis: Survival Benefit for African-Americans with Advanced Prostate Cancer
Contrary to current perceptions, certain African-American men with advanced prostate cancer have as good a chance of survival as white men and might actually have a small advantage, according to a new analysis of more than 8,000 patients who participated in clinical trials. In a study presented...
Smell Receptor Fuels Prostate Cancer Progression
When scientists first described the receptors responsible for our sense of smell, they naturally assumed that these chemical sensors resided exclusively in the lining of our noses. But then olfactory receptors started turning up in the strangest places -- the lungs, liver, skin, heart, testes and...
Our Journey with Prostate Cancer
I met Donald “Don” Ward in the spring of 1994 in a Sacred Harp singing group in Palo Alto, California. Over time, we struck up an acquaintance and started dating, and from our first date, we were perfect together. On our early outings, we hiked in the coastal hills between Palo Alto and the Pacific...
Bone Scan Software Accurately Calculates Prognosis of Advanced Prostate Cancer
A software tool to automatically calculate how extensively bones have been infiltrated by prostate cancer is both accurate and speedy, capturing key prognostic information related to survival and the development of symptoms over time. The software, called the automated bone scan index, was tested...
Utah Cancer Expert Named Chair Of Department of Medicine
Kathleen Cooney, MD, a medical oncologist and internationally known physician scientist, has been named chair of the Department of Medicine at Duke University School of Medicine. Cooney joins Duke from the University of Utah School of Medicine, where she is the H.A. and Edna Benning Presidential...
New Advances in Overcoming Prostate Cancer Disparities
African American men are nearly two times more likely to develop prostate cancer than white men and nearly three times more likely to die from the disease. In North Carolina, the rate of prostate cancer-related deaths among African Americans is higher than the national average. Researchers at the...
Free Prostate Cancer Screening (9.8 and 9.9.18)
Men between the ages of 45‐75 who have never been diagnosed with prostate cancer, are invited to come and get a free onsite prostate cancer screening; including prostate specific antigen (PSA) and digital rectal exam (DRE), at the locations and times listed below. Free blood pressure exams,...
Gospel Singer Gives Hereditary Cancer Diagnosis A Different Tune
Every Sunday, you can find Marisha Hargrove, 28, at the front of her hometown church leading the congregation in worship with gospel songs. Marisha’s voice is strong and powerful as she belts out her favorite song “I Don’t Know About Tomorrow,” bringing churchgoers to its feet. The ballad’s lyrics...
Aptamers May Form New, Safer Chemotherapy Delivery Systems
Using chemotherapy along with aptamers—lab-made molecules that function like antibodies—Duke Health researchers showed that they can zero in on and kill prostate cancer tumors in mice while leaving healthy tissue unscathed. The finding suggests that aptamers could form the basis of new cancer...
IRONMAN Enrolling Prostate Cancer Patients
The International Registry for Men with Advanced Prostate (IRONMAN), the first international clinical trial registry for prostate cancer, is open for enrollment. The registry aims to enroll 5,000 patients over the next three years at several institutions worldwide, including 2,500 from the United...
For Virginia Man, The New Year Was Nothing To Toast
As a new year ushers in, so does a time of renewed hope and new beginnings. Instead of ringing in the new year as is customary, Curtis Garbett found himself during the waning hours of 2015 learning he had cancer. “I couldn’t believe what I was hearing,” said Garbett. “I was only 39 years old; my...
Genetic Testing Inspires Pioneering Discovery
The Symons family has taken the famous song lyric “from sea to shining sea” to an entirely new level. Rather than simply traveling from state-to-state to see America, the family committed to literally running from coast-to-coast by competing in each of the 50 states. However, along the way they...
Duke Nurse Turned Cancer Survivor
Bethany Clements, 54, has been an oncology nurse at Duke Cancer Institute for the past 25 years. Clements dedicated her career to helping others battling cancer, but in May 2011 she found herself facing her own personal battle with cancer. During one evening work shift, Clements, in an ironic twist...
Research Oncology Team Turns The Tables On Obligatory Gift-Giving Tradition
What do you give to someone who has just about everything he or she needs? After years of giving what had become the “same ol’, same ol,’” the Genitourinary Research Oncology Team decided to add a twist to the annual obligatory tradition. Armed with a heart for others, the group wrapped up the...